Ionis Pharmaceuticals: Q3 Earnings Snapshot
CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Thursday reported a loss of $147 million in its third quarter.
The Carlsbad, California-based company said it had a loss of $1.03 per share.
The results fell short of Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $1.01 per share.
The drug discovery and development company posted revenue of $144 million in the period, beating Street forecasts. Ten analysts surveyed by Zacks expected $139.4 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS
